Sales rise 10.59% to Rs 5366.40 crore
Net profit of Zydus Lifesciences rose 298.62% to Rs 1182.30 crore in the quarter ended March 2024 as against Rs 296.60 crore during the previous quarter ended March 2023. Sales rose 10.59% to Rs 5366.40 crore in the quarter ended March 2024 as against Rs 4852.50 crore during the previous quarter ended March 2023.For the full year,net profit rose 96.88% to Rs 3859.50 crore in the year ended March 2024 as against Rs 1960.30 crore during the previous year ended March 2023. Sales rose 12.70% to Rs 19021.50 crore in the year ended March 2024 as against Rs 16877.80 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales5366.404852.50 11 19021.5016877.80 13 OPM %30.3825.88 -28.3122.87 - PBDT1752.301265.70 38 5587.203916.60 43 PBT1547.001087.10 42 4823.103193.90 51 NP1182.30296.60 299 3859.501960.30 97
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
